Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokines and Chemokines in Erythema Migrans
NCT02147249Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jul 2013
- Primary completion
- Dec 2020
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of doxycycline, cefuroxime axetil and amoxicillin in erythema migrans (EM), sponsored by University Medical Centre Ljubljana. Primary endpoint: inflammatory proteins in erythema migrans patients up to 12 months. Status: unknown.
02
Drugs
doxycyclinecefuroxime axetilamoxicillin
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT02147249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147249.